Skip to main content
GutCited

L-Glutamine لـ Crohn's Disease

C

Small RCTs show glutamine (0.5 g/kg/day) improves intestinal permeability and morphology in Crohn's patients. Evidence limited by small sample sizes.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'gutcited.com'; const params = 'ingredient\u003Dl\u002Dglutamine\u0026condition\u003Dibd\u002Dcrohns\u002Ddisease'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

C

الخلاصة

Small RCTs show glutamine (0.5 g/kg/day) improves intestinal permeability and morphology in Crohn's patients. Evidence limited by small sample sizes.

Key Study Findings

Other
Multiomics reveals microbial metabolites as key actors in intestinal fibrosis in Crohn's disease.
Dose: None مقابل: None Outcome: Gut microbiota composition التأثير: None None

المجتمع المدروس: Crohn's disease patients

Controlled Clinical Trial
Washed microbiota transplantation for Crohn's disease: A metagenomic, metatranscriptomic, and metabolomic-based study.
Dose: Washed microbiota transplantation (WMT) مقابل: Pre-treatment baseline Outcome: Clinical remission and multi-omics changes التأثير: None None

المجتمع المدروس: Patients with Crohn's disease

Other
Multi-Omics Reveals the Effects of Cannabidiol on Gut Microbiota and Metabolic Phenotypes.
Dose: None مقابل: None Outcome: Cholesterol levels التأثير: None None

المجتمع المدروس: Mouse model

Observational Study n=262
Gut Microbiome-Generated Phenylacetylglutamine from Dietary Protein is Associated with Crohn's Disease and Exacerbates Colitis in …
Dose: Phenylacetylglutamine (PAGln, measured) مقابل: Healthy controls (n=126) Outcome: PAGln association with CD and colitis التأثير: None None

المجتمع المدروس: New-onset treatment-naive CD (n=136) + controls

In Vitro
Constitutively active autophagy in macrophages dampens inflammation through metabolic and post-transcriptional regulation of cytokine production.
Dose: Beclin1 constitutive activation (genetic) مقابل: Wild-type mice Outcome: Cytokine production in macrophage activation التأثير: None None

المجتمع المدروس: Beclin1 variant mice + AIEC infection

Review
[Regulation of inflammatory bowel disease by amino acids].
Dose: None مقابل: None Outcome: None التأثير: None None

المجتمع المدروس: IBD patients

Key Statistics

3

الدراسات

200

المشاركون

Positive

C

التقييم

Referenced Papers

Sheng wu gong … 2022 4 اقتباسات
The Cochrane database … 2018 425 اقتباسات
Gastroenterology clinics of … 2018 67 اقتباسات
Current opinion in … 2017 37 اقتباسات
The Cochrane database … 2016 37 اقتباسات
Scandinavian journal of … 2014 56 اقتباسات
Inflammatory bowel diseases 2010 89 اقتباسات
Nutrition in clinical … 2009 36 اقتباسات
Molecular nutrition & … 2008 26 اقتباسات
The Cochrane database … 2007 192 اقتباسات
Current opinion in … 2005 22 اقتباسات
JPEN. Journal of … 2005 19 اقتباسات
Clinical nutrition (Edinburgh, … 2004 18 اقتباسات
Medycyna wieku rozwojowego 2004 1 اقتباسات
Alimentary pharmacology & … 2003 179 اقتباسات
Revista do Hospital … 2002 39 اقتباسات
Current opinion in … 2002 1 اقتباسات
Current opinion in … 2002
The Cochrane database … 2001 149 اقتباسات
Current opinion in … 2000 21 اقتباسات
JPEN. Journal of … 2000 18 اقتباسات
Diseases of the … 1998 26 اقتباسات
Zeitschrift fur Gastroenterologie 1998 18 اقتباسات
Schweizerische medizinische Wochenschrift. … 1996

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

الجرعات الشائعة

general:
5-15 g/day
ibsdsupport:
5 g three times daily (15 g/day total)
postexercisegut:
0.25-0.9 g/kg before intense exercise
gutbarriersupport:
0.5 g/kg/day (approximately 30-40 g/day for adults)

الحد الأعلى: Generally well-tolerated up to 0.5 g/kg/day; caution above 40 g/day

الجرعات المدروسة في الأبحاث

الجرعة المدة التأثير ن
None -- Positive --
Washed microbiota transplantation (WMT) -- Positive --
None -- Positive --
Phenylacetylglutamine (PAGln, measured) -- Negative 262
Beclin1 constitutive activation (genetic) -- Positive --
None -- Mixed --
None -- Negative --
None -- Mixed --

أفضل وقت للتناول: Between meals or before exercise; divide doses throughout the day

Safety & Side Effects

الآثار الجانبية المُبلّغ عنها

  • Mild gastrointestinal discomfort at high doses
  • Headache
  • Dizziness at very high doses
  • Potential glutamate excitotoxicity concerns in neurological conditions (theoretical)

التفاعلات المعروفة

  • Lactulose (glutamine may reduce the efficacy of lactulose for hepatic encephalopathy)
  • Anti-seizure medications (glutamine converts to glutamate; theoretical concern)
  • Chemotherapy agents (glutamine may protect cancer cells; discuss with oncologist)

الحد الأقصى المسموح به: Generally well-tolerated up to 0.5 g/kg/day; caution above 40 g/day

استشر مقدم الرعاية الصحية دائماً قبل البدء بأي مكمل غذائي.

Frequently Asked Questions

Does L-Glutamine help with Crohn's Disease?
Based on 3 studies with 200 participants, there is limited but promising evidence that L-Glutamine may support Crohn's Disease management. Our evidence grade is C (Some Evidence).
How much L-Glutamine should I take for Crohn's Disease?
Studies have used various dosages. A commonly studied range is 5-15 g/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of L-Glutamine?
Reported side effects may include Mild gastrointestinal discomfort at high doses, Headache, Dizziness at very high doses, Potential glutamate excitotoxicity concerns in neurological conditions (theoretical). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for L-Glutamine and Crohn's Disease?
We rate the evidence as Grade C (Some Evidence). This rating is based on 3 peer-reviewed studies with 200 total participants. The overall direction of effect is positive.

Related Evidence

إخلاء مسؤولية FDA: لم تُقيَّم هذه البيانات من قبل إدارة الغذاء والدواء (FDA). لا تهدف المنتجات والمعلومات الواردة في هذا الموقع إلى تشخيص أو علاج أو شفاء أو الوقاية من أي مرض. تستند تقييمات الأدلة المعروضة إلى تحليلنا للأبحاث المحكّمة المنشورة ولا تُشكّل نصيحة طبية. استشر مقدم الرعاية الصحية دائماً قبل البدء بأي نظام مكملات.